Tetrahydrocoptisine
CAS: 4312-32-7
Ref. TM-T4S2063
1mg | 52,00 € | ||
5mg | 94,00 € | ||
10mg | 150,00 € | ||
25mg | 245,00 € | ||
50mg | 362,00 € | ||
100mg | 533,00 € |
Produktinformation
- STYLOPINE
- (RS)-Stylopine
- (S)-stylopine
- (±)-Stylopine
- 2,3:9,10-Bis(methylenedioxy)-13a-berbine
- 2,3:9,10-Bis(methylenedioxy)berbine
- 4H-Bis[1,3]benzodioxolo[5,6-a:4′,5′-g]quinolizine, 6,7,12b,13-tetrahydro-
- 4H-[1,3]benzodioxolo[5,6-a]-1,3-benzodioxolo[4,5-g]quinolizine, 6,7,12b,13-tetrahydro-
- 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine
- 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4′,5′-g]quinolizine
- Mehr Synonyme anzeigen
- 7461-02-1
- Berbine, 2,3:9,10-bis(methylenedioxy)-, (±)-
- Chelidamine
- NSC 110382
- NSC 404529
- Stylopine (VAN)
- dl-Stylopine
- dl-Tetrahydrocoptisine
1. Tetrahydrocoptisine (STYLOPINE) has effective effects in suppressing inflammation. 2. Tetrahydrocoptisine possesses a protective effect on LPS-induced ALI through inhibiting of NF-κB signaling pathways, which may involve the inhibition of pulmonary inflammatory process. 3. Tetrahydrocoptisine has gastroprotective activity, is attributed to reducing NO production and adjusting the pro-inflammatory cytokine, inhibited neutrophil accumulation and NF-κB expression. 4. Tetrahydrocoptisine is an active anti-inflammatory constituent by inhibition of TNF-α, IL-6 and NO production possibly via down-regulation of NF-κB activation, phospho-ERK1/2 and phospho-p38MAPK signal pathways.
Chemische Eigenschaften
Technische Anfrage zu: TM-T4S2063 Tetrahydrocoptisine
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.